NCT00050856View on ClinicalTrials.gov

Fuzeon (Enfuvirtide) Early Access Program for Patients With HIV-1 Infection

PHASE3CompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

November 30, 2002

Study Completion Date

November 30, 2003

Conditions
HIV Infections
Interventions
DRUG

Enfuvirtide T/20/Ro 29,9800, HIV-1 Infusion Inhibitor

Trial Locations (1)

20892

National Institute of Allergy and Infectious Diseases (NIAID), Bethesda

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00050856 - Fuzeon (Enfuvirtide) Early Access Program for Patients With HIV-1 Infection | Biotech Hunter | Biotech Hunter